SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-093864
Filing Date
2010-10-18
Accepted
2010-10-18 16:08:02
Documents
3
Period of Report
2010-10-18
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K o65843e8vk.htm 8-K 12003
2 EX-99.1 o65843exv99w1.htm EX-99.1 6368
3 GRAPHIC o65843o6584300.gif GRAPHIC 4558
  Complete submission text file 0000950123-10-093864.txt   26356
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 101128168
SIC: 2835 In Vitro & In Vivo Diagnostic Substances